Management of Carfilzomib-Associated Cardiac Adverse Events.

This article discusses the cardiac-related adverse events that have been reported in clinical studies of carfilzomib and presents a single institution perspective on the prevention and management of cardiac adverse events following treatment with this agent.
PMID: 26907720 [PubMed - as supplied by publisher]

Source: Clinical Lymphoma and Myeloma - February 4, 2016 Category: Cancer & Oncology Authors: Mikhael J Tags: Clin Lymphoma Myeloma Leuk Source Type: research